Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 790

1.

[AML1 gene signal patterns and clinical significance in 337 patients with B-cell acute lymphoblastic leukemia].

Huang H, Lin YY, Xiong F, Xu HY, Wu Y, Yang WP.

Zhonghua Bing Li Xue Za Zhi. 2016 Feb 8;45(2):111-2. doi: 10.3760/cma.j.issn.0529-5807.2016.02.009. Chinese. No abstract available.

PMID:
26879433
2.

Co-existence of AML1-ETO and BCR-ABL1 transcripts in a relapsed patient of acute myeloid leukemia with favorable risk group: A coincidence or clonal evolution?

Singh MK, Gupta R, Rahman K, Kumar S, Sharma A, Nityanand S.

Hematol Oncol Stem Cell Ther. 2016 Jan 16. pii: S1658-3876(16)00005-4. doi: 10.1016/j.hemonc.2015.12.003. [Epub ahead of print]

3.

Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO.

Roh SH, Kasembeli M, Galaz-Montoya JG, Trnka M, Lau WC, Burlingame A, Chiu W, Tweardy DJ.

J Biol Chem. 2016 Feb 26;291(9):4732-41. doi: 10.1074/jbc.M115.684878. Epub 2015 Dec 24.

PMID:
26706127
4.

PARP Inhibitors Suppress AML1-ETO- and PML-RARα-Positive Leukemia.

[No authors listed]

Cancer Discov. 2016 Jan;6(1):12. doi: 10.1158/2159-8290.CD-RW2015-227. Epub 2015 Dec 3.

PMID:
26634675
5.

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation.

Arora R, Sawney S, Saluja D.

Curr Cancer Drug Targets. 2016;16(3):215-25.

PMID:
26563884
6.

Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.

Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, Chen S, Chen Z, Wang K.

Blood. 2016 Jan 14;127(2):233-42. doi: 10.1182/blood-2015-03-626671. Epub 2015 Nov 6.

PMID:
26546158
7.

Identification of TEL-AML1 (ETV6-RUNX1) associated DNA and its impact on mRNA and protein output using ChIP, mRNA expression arrays and SILAC.

Linka Y, Ginzel S, Borkhardt A, Landgraf P.

Genom Data. 2014 May 27;2:85-8. doi: 10.1016/j.gdata.2014.05.010. eCollection 2014 Dec.

8.

Increased expression of amyloid precursor protein promotes proliferation and migration of AML1/ETO-positive leukemia cells and be inhibited by panobinostat.

Wang CL, Ding BJ, Jiang L, Yin CX, Zhong QX, Yu GP, Li XD, Meng FY.

Neoplasma. 2015;62(6):864-71. doi: 10.4149/neo_2015_105.

PMID:
26458322
9.

UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.

Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC.

Leukemia. 2016 Mar;30(3):728-39. doi: 10.1038/leu.2015.275. Epub 2015 Oct 9.

10.

Mitotic crossover promotes leukemogenesis in children born with TEL-AML1 via the generation of loss of heterozygosity at 12p.

Ivanovski I, Garavelli L, Djurić O, Ćirović A, Škorić D, Ivanovski PI.

Pediatr Med Chir. 2015 Jun 30;37(2):pmc.2015.112. doi: 10.4081/pmc.2015.112.

11.

[A case report of childhood acute lymphoblastic leukemia with intrachromosomal amplification of AML1 gene in chromosome 21 and TEL deletion].

Yang W, Xiong F, Huang H, Wu Y, Lin Y, Fan X, Liu Z, Zhang X, Xu H, Zeng H, Zeng S.

Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):569. doi: 10.3760/cma.j.issn.0253-2727.2015.07.008. Chinese. No abstract available.

PMID:
26304079
12.

Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.

Wang XW, Xu YH.

Genet Mol Res. 2015 Jul 14;14(3):7883-93. doi: 10.4238/2015.July.14.14.

13.

Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis.

Mizutani S, Yoshida T, Zhao X, Nimer SD, Taniwaki M, Okuda T.

Br J Haematol. 2015 Sep;170(6):859-73. doi: 10.1111/bjh.13499. Epub 2015 May 26.

PMID:
26010396
14.

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.

Trombly DJ, Whitfield TW, Padmanabhan S, Gordon JA, Lian JB, van Wijnen AJ, Zaidi SK, Stein JL, Stein GS.

BMC Genomics. 2015 Apr 17;16:309. doi: 10.1186/s12864-015-1445-0.

15.

The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.

de Laurentiis A, Hiscott J, Alcalay M.

Oncogene. 2015 Dec 3;34(49):6018-28. doi: 10.1038/onc.2015.50. Epub 2015 Apr 20.

PMID:
25893288
16.

Esculetin Downregulates the Expression of AML1-ETO and C-Kit in Kasumi-1 Cell Line by Decreasing Half-Life of mRNA.

Sawney S, Arora R, Aggarwal KK, Saluja D.

J Oncol. 2015;2015:781473. doi: 10.1155/2015/781473. Epub 2015 Mar 11.

17.

AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation.

Gao XN, Yan F, Lin J, Gao L, Lu XL, Wei SC, Shen N, Pang JX, Ning QY, Komeno Y, Deng AL, Xu YH, Shi JL, Li YH, Zhang DE, Nervi C, Liu SJ, Yu L.

Leukemia. 2015 Aug;29(8):1730-40. doi: 10.1038/leu.2015.56. Epub 2015 Mar 2.

PMID:
25727291
18.

[Construction of SIRT1 promoter expression vector and its activity analysis as well as influence of AML1-ETO on transcriptional regulation of SIRT1 gene].

Wang Q, Dou LP, Li YH, Wang LL, Zhou L, Li DD, Wang LJ, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Feb;23(1):12-8. doi: 10.7534/j.issn.1009-2137.2015.01.003. Chinese.

PMID:
25687038
19.

[Clinical efficacy of decitabine combined with modified CAG regimen for relapsed-refractory acute myeloid leukemia with AML1-ETO⁺].

Jing Y, Zhu CY, Zhang Q, Niu JH, Yang H, Liu SY, Zhu HY, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1245-50. doi: 10.7534/j.issn.1009-2137.2014.05.011. Chinese.

PMID:
25338566
20.

[FLT3 gene overexpression and its clinical significance in acute myeloid leukemia with AML1/ETO fusion gene positive].

Xie HM, Gao L, Wang N, Xu YY, Shi JL, Yu L, Wang LL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1199-205. doi: 10.7534/j.issn.1009-2137.2014.05.002. Chinese.

PMID:
25338557
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk